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Abstract
Background: Red raspberry possesses potent antioxidant capacity and antiproliferative activity against cancer
in vitro.
Methods: The objective of this study was to determine the protective effects of raspberry 80% acetone extract in a
rat hepatic lesions model induced by diethylnitrosamine (DEN). Rats were treated with the red raspberry extract
(0.75, 1.5 or 3.0 g/kg of body weight) by gavage starting 2 h after DEN administration and continuing for 20 weeks.
Results: A dose-dependent inhibition by red raspberry extract of DEN-induced hepatic nodule formation which
stands for hepatic lesions was observed. Corresponding hepatic nodule incidence rates were 45.0, 40.0, 25.0 and
5.0% in positive control, low, middle and high groups, respectively (P < 0.01 or 0.05). Gross findings,
histopathological and ultrastructural evaluations of hepatic lesion were performed on 9, 8, 5 and 1 hepatic nodule
in positive control, low, middle and high doses of groups, respectively, identified in rats from the respective groups
of 20. A decreasing trend of proportions of hepatocellular carcinoma masses accompanied the increasing doses of
red raspberry extract.
Conclusions: These findings demonstrate that the potent capacity of red raspberry diet could not only suppress
DEN-induced hepatic lesions in rats, but also reduce the definite diagnostic features of neoplasm.
Background
Hepatic cancer is a major public health problem
throughout the entire world. It was estimated that
approximately 24,120 new cases would be diagnosed
and more than 18,910 people died from hepatic and
intrahepatic bile duct cancers in the United Stated alone
in 2010 [1]. Although the incidence rate of hepatic can-
cer has been falling in most countries worldwide, the
decrease has been slower in developing countries than
that in the developed countries [2]. By contrast the inci-
dence of primary hepatic cancer is increasing in several
developed countries, including the United States [2].
Although diagnosis and treatment are the major
strategies of controlling cancer, chemoprevention is one
of the best strategies for prevention.
Lifestyle and/or environmental factors, especially diet-
ary factors, play an important role in influencing cancer
risk. It has been reported that more than 30% of human
cancers could be prevented by an alternative strategy of
appropriate dietary modification [3,4]. Epidemiological
and laboratory studies, including case-control and
cohort studies, have consistently shown that regular
consumption of fruits and vegetables is associated with
a markedly reduced risk of developing cancer and other
chronic diseases [5-12]. Based on the findings that a
high consumption of fruit and vegetables is inversely
related to a risk of hepatic cancer [11], scientists have
suggested that possible anticarcinogenic mechanisms of
phytochemicals in fruits and vegetables are primary con-
tributors to the health benefits in the chemoprevention
of cancer [13,14]. The health benefits of raspberry or
raspberry constituents have been ascribed to: antioxi-
dant [15,16], anti-inflammation [17], low body weight
[18], and inhibitory cancer cell growth [19-21]. In
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any medium, provided the original work is properly cited.previous studies, raspberry extract and its constituents
had potent antioxidant capacity, and inhibited the
growth of mammary, oral, colon, prostate and liver can-
cer cells in a dose-dependent manner [19,22]. However,
it is not reported that whether raspberry extract inhibits
hepatic lesions induced by chemical in an animal model.
The objective of the present study was to determine
whether raspberry phytochemical extract prevented
against hepatic lesions in a rat model.
Methods
Red Raspberry Extraction
The red raspberries (Rubus idaeus L.) were purchased
from a supermarket in China. Fresh red raspberries
were cleaned before extraction. The red raspberries
were extracted using the method reported previously in
our laboratory [9,12]. Briefly, 100 g of fresh weight of
the red raspberries were weighed and homogenized with
chilled 80% acetone (1:2, w/v) using a chilled Waring
blender for 5 min. The sample was then further homo-
genized using a Polytron homogenizer for an additional
3 min. The homogenates were filtered through What-
man #1 filter paper on a Buchner funnel under vacuum.
The filtrate was evaporated at 45°C until approximately
90% of the filtrate had been evaporated. The raspberry
extract was standardized to contain 437.62 ± 29.94 mg
total phenolics (gallic acid equivalents) per 100 g rasp-
berries. The standardized raspberry extracts were frozen
and stored at -80°C until use in the feeding study. Con-
trol extracts were also prepared using the same extrac-
tion solvents and procedures without red raspberries.
Animal Care and Treatment
Pathogen-free male Wistar rats, 130 - 140 g of body
weight, were purchased from Sino-British SIPPR/BK Lab
Animal Ltd (Shanghai, China). The rats adapted imme-
diately to the AIN-93 M diet and were housed in a
room with a 12 h light/12 h dark cycle. The rats were
acclimated to the surroundings in the animal room for
1 week prior to the initiation of the experiment. Care
and treatment of rats followed the recommended guide-
lines of the National Research Council (1985). The rats
were randomly assigned to five groups (n = 20/group).
Three raspberry treated and positive control groups of
rats were given 10 mg/kg body weight of diethylnitrosa-
mine (DEN, Sigma Chemical Co., St. Louis, MO) water
solution by gavage once and continue to drink 0.025%
DEN water ad libitum for 20 weeks; the fifth group
which received no DEN but was given 1 mL of distilled
water served as the negative control group. Rats were
administered the control extracts or red raspberry
extract starting 2 h after DEN administration and conti-
nuing for 20 weeks. Three levels of low, middle, and
high doses of red raspberry extract were given to the
rats by gavage corresponding to 0.75, 1.5, and 3.0 g
fresh raspberry/kg/day body weight raspberry extract,
respectively. The control groups fed with control extrac-
tion. Animals were weighed weekly. All animals were
sacrificed under anesthesia at the end of the 20
th week
after DEN administration. Livers were rapidly removed
and weighed. The relative liver weight was calculated on
the basis of final body weights. Livers were cut into 5 to
8 sections to find whether there have nodules which
were stand for hepatic lesions of rat induced by DEN.
Light and Electron Microscope
Part of nodules from the positive control and experi-
mental groups were fixed in 10% neutral formalin solu-
tion and subsequently dehydrated and embedded in
paraffin. The tissue wax was cut into 5 μms e c t i o n s ,
fixed on slides and processed for microscopy examina-
tion (stained with hematoxylin and eosin, H&E) ana-
lyses. Histopathological evaluation was carried out on
coded slides following the IARC (International Agency
for Research on Cancer) classification of rodent hepatic
lesions [23]. Two independent pathologists evaluated
these sections in a double blind manner. Both investiga-
tors under a multihead microscope reassessed the sec-
tions in cases of disagreement.
For transmission electron microscopy (TEM), portions of
nodules were removed by dissection and fixed at 4°C for
1 - 4 h in 3% glutaraldehyde in 0.2% sodium cacodylate
buffer (pH 7.0) containing 30 mg/mL NaCl and 2 μg/mL
CaCl2; postfixation followed at 4°C for 4 h in 1% OsO4
minus salts. Sections were rinsed twice in 0.2 mol/L
sodium cacodylate buffer and dehydrated through a graded
ethanol series. Subsequently, the sections were immersed
with Epon 821, embedded in capsules and converged at
60°C for 72 h, and then ultrathin sections (60 nm) were
prepared and stained with uranyl acetate and lead citrate.
The ultrastructure of cells was examined by TEM [24].
Statistical Analysis
Data were expressed as mean ± S.D. A one-way analysis
of variance was used to analyze body weight. Fisher’s
Exact Test was used to compare the percentage of rats
with liver lesions and histology in each group. Data ana-
lyses were generated and plots were constructed using
SPSS for Windows version 18.0 (SPSS Inc., Chicago, IL)
and SigmaPlot version 11.20 for Windows (Systat Soft-
ware Inc., San Jose, CA). Statistical significance was set
at P < 0.05 or P < 0.01.
Results
Effects of Raspberry Extract on the Prevention of
Hepatic Lesions
Body weights of animals in each group are presented in
Figure 1. Throughout the experiment, there were no
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raspberry extract and animals in the controls groups
(P > 0.05). At the termination of the experiment (20
weeks) the relative weights of liver were not significantly
different between the negative control and raspberry
treated groups (P > 0.05) (Table 1). Rats treated with
the carcinogen DEN developed hepatic lesions with
45.0% nodule incidence in the positive control group,
and 40.0, 25.0, and 5.0% in animals fed the three levels
of low, middle, and high doses of raspberry extract,
respectively, during the 20-week study. No tumors were
detected in the negative control group without DEN
(Table 1). Application of low, middle, and high doses of
raspberry extract reduced the nodule incidence by 11.1,
44.4, and 88.9% (P <0 . 0 5a n dP < 0.01), respectively, in
a dose-dependent manner (Table 1). Total nodule num-
bers in the control group and the three levels of low,
middle, and high dose groups were 9, 8, 5, and 1,
respectively, in a dose-dependent manner (Table 1).
Gross findings of rat liver in DEN-induced hepatic lesions
At the termination of the experiment, the rats were
necropsied, and 5 to 8 sections were taken per liver,
which enabled us to examine nodules. Nine of twenty
rats in the positive control group demonstrated grossly
visible, tan nodu1es, which bulged from the external
and cut surface of the liver (Figure 2A). The nodules
were light gray to yellow-tan or blue and were more
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Figure 1 Body weight. Wistar rats were fed three levels of 0.75 (low), 1.5 (middle), and 3.0 (high) g of fresh red raspberries/kg of body weight
after diethylnitrosamine (DEN) administration and continuing for 20 weeks. Control -, negative control group; control +, positive control group.
Table 1 Preventive effects of hepatocarcinogenesis of red raspberry extract in a Wistar rat model
a
Group no. DEN dose
(g/kg of b.w.)
no. of rats with nodules/total no. of rats nodule incidence
(%)
liver index (g/100 g b.w.)
(mean ± S.D.)
High 20 + 3.0 1/20 5.0** 2.61 ± 0.49
Middle 20 + 1.5 5/20 25.0* 2.66 ± 0.18
Low 20 + 0.75 8/20 40.0 2.78 ± 0.50
Control - 20 - - 0/20 0.0 2.90 ± 0.78*
Control + 20 + - 9/20 45.0 2.54 ± 0.23
a* ,P < 0.05, **, P < 0.01, compared to the corresponding positive control group. Control -, negative control group; control +, positive control group. B.w., body
weight.
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tissue (Figure 2B). These nodules were present uni-
formly in all lobes and measured from 2 to 8 mm in
diameter. Many of the nodules on the liver surface were
elevated (Figures 2A and 2C). The nodules in both the
low dose of raspberry treatment and positive control
groups were sharply demarcated from the surrounding
hepatic parenchyma (Figures 2A and 2C). The larger
nodules in the positive control group were dull gray,
central, soft loci, which upon microscopic examination
were seen to be areas of necrosis. No nodules were
found in the surface of rat livers in the middle and high
doses of raspberry treatments (Figures 2D and 2E). The
nodules were evidently fewer in the raspberry treatments
than those of the positive control group. The number of
rats with hepatic nodules was 8 of 20, 5 of 20, and 1 of
20 rats in the low, middle, and high dose of raspberry
treatments, respectively. The livers in the negative con-
trol group were soft, pinkish-brown, triangular organs
and no nodules were found on the surface or within the
livers (Figure 2B).
Histological Findings
The nodules taken from rat livers of raspberry treated
and positive control groups were examined by histo-
pathology. Histopathological findings of liver sections
from various experimental groups of animals are illu-
strated in Figure 3. Based on the IARC classification of
hepatic lesions, there are three major types of histo-
pathological changes of rat hepatic lesions: hyperplasia,
fibrosis and hepatocellular adenocarcinoma. In present
study, the livers of negative control animals showed nor-
mal hepatocellular architecture. Three types of hepatic
lesions were found in positive, low, and middle groups.
Only one rat with hepatic hyperplasia was found in high
dose of raspberry-treated group. The percentages of
hepatocellular carcinomas in hepatic tumors in rats trea-
ted with the carcinogen DEN were as follows: 55.6%
hepatocellular adenocarcinoma in the positive control,
and 25.0, 40.0, and 0% in low, middle and high rasp-
berry extract group, respectively. Although there was no
significant differences between fibrosis and hyperplasia,
increasing trend of hyperplasia and decreasing trend of
fibrosis were observed through the raspberry treatment
groups from low to high (Table 2). The histological
types of hepatic lesion tissues in the positive control and
raspberry treated groups are shown in Figure 2 and
Table 2.
Ultrastructural Findings
Transmission electron microscopy (TEM) was used to
determine morphological ultrastructure of hepatic tissue
sections. The ultrastructural findings of hepatic tissues
of rats treated with red raspberry extract or controls are
shown in Figure 4. Epon-embedded sections of hepatic
tissue showed regular cellular membrane, organelle, and
clear nuclear structure (Figure 4A). The neoplastic cells
had an abundant cytoplasm either finely and homoge-
neously granular or containing multiple small cytoplas-
mic vacuoles and some widely scattered hyperchromatic
variable-sized nuclei (Figure 4B). Nuclear inclusion
appeared, rough endoplasmic reticulum degranulated
and vacuoles formed in the cytoplasm (Figure 4B).
Many ribosomes were scattered throughout the cyto-
plasm and these often formed polysomes (Figures 4A,
4C and 4D). Mitochondria were largely granular matrix
(Figure 4C). Rough endoplasmic reticulum in parallel or
nonparallel array was a common cytoplasmic organelle
(Figures 4C and 4D). Numerous densely osmiophilic,
irregularly shaped, diminutive electron-opaque
Figure 2 Gross findings of rat hepatic surface in the raspberry treatments and positive control groups. The nodules in the hepatic
surface were marked by arrows. Grossly visible or tan nodules of hepatic surface were found in the positive control group (A) and low dose of
raspberry treated group (C). No nodules in the hepatic surface were found in the negative control group (B), middle (D) and high (E) doses of
raspberry treatments.
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substructure and definite diagnostic features were con-
sistent with the appearance of lysosomes (Figures 4C
and 4D). In this study, DEN-induced hepatic neoplasm
of rat in the positive control group showed the ultra-
structural changes such as rich endoplasmic reticulum,
appearing polyribosomes and monoparticulate glycogen,
widely scattered hyperchromatic variable-sized nuclei.
However, these changes were lessened in the raspberry
treatments. Thus, red raspberry diet could not only
reduce nodule incidence, but also reduce markers of
definite diagnostic features of neoplasm.
Discussion
Red raspberry has been used throughout the centuries
for nutritional and medicinal purposes. In a previous
study, the red raspberry extract showed a significant
inhibition of growth of human oral (KB, CAL-27), breast
(MCF-7), colon (HT-29, HCT116), and prostate
(LNCaP) tumor cell lines at doses ranging from 25 to
200 μg/mL and stimulation of apoptosis of the Cox-2
expressing colon cancer cell line, HT-29 [19]. Liu et al.
also showed that four varieties of raspberry significantly
inhibited the proliferation of HepG2 human liver cancer
cells in a dose-dependent manner [22]. In another
study, red raspberry extract significantly inhibited the
proliferation of human hepatic cancer HepG2 and
human colon cancer CaCo-2 cells in a dose-dependent
manner [22,25]. The red raspberry extract was also
shown to inhibit cell proliferation of HT-29 colon can-
cer mainly via the p21
WAF1 pathway [26]. The red rasp-
berry extract and its components reduced endogenous
oxidative DNA damage in vitro and in vivo [27].
Diethylnitrosamine (DEN) is a representative chemical
carcinogen with the potential to cause tumors in various
organs, including the liver, skin, gastrointestinal tract,
and respiratory system. DEN is a complete carcinogen
to induce hepatocellular carcinoma [28]. DEN is also
Figure 3 Histopathological findings in hepatic tumors stained with HE: (A, B) HE-stained section ofan o r m a lh e p a t i co r g a ni nt h e
negative control group (10× and 40×); (C, D) HE-stained section of a hyperplasia in the high dose group (10× and 40×); (E, F) HE-
stained section of a fibrosis (10× and 40×) in the middle dose group; (G, H) HE-stained section of a moderately differentiated
hepatocellular carcinoma in the positive control group (10× and 40×). The neoplastic cells are large, oval- or irregular-shaped, and their
cytoplasm is abundant. The nuclei are enlarged, binucleated and pleomorphic nuclei with granular chromatin. Sometimes large basophilic
hyperchromatic nuclei are also noticed. The cytoplasm is loose and irregularly extensive vacuolated with masses of acidophilic materials,
although this was not invariable.
Table 2 Classes of hepatic lesions in the control and red raspberry-treated groups
a
group animal
(n)
no. of rats with nodules
(n)
hyperplasia
(n) (%)
fibrosis
(n) (%)
hepatocellular carcinoma
(n) (%)
High 20 1 1 (100.0) 0 (0.0) 0* (0.0)
Middle 20 5 1 (20.0) 2 (40.0) 2 (40.0)
Low 20 8 2 (25.0) 4 (50.0) 2 (25.0)
Control - 20 0 0 (0.0) 0 (0.0) 0 (0.0)
Control + 20 9 2 (22.2) 2 (22.2) 5 (55.6)
a*, P < 0.05, compared to the positive control group (control +).
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rat that mimic the different types of benign and malig-
nant tumors in human [29,30]. In this study, rats were
fed three levels of 0.75 (low), 1.5 (middle), and 3.0
(high) g fresh red raspberries/kg body weight per day
starting after DEN administration and continuing for 20
weeks. The positive control group with carcinogen DEN
developed hepatic lesions with 45.0% nodule incidence
and no nodules were detected in the negative control
group without DEN. A dose-dependent inhibition of
hepatic lesions by fresh red raspberry extract was
observed (Table 1). These results demonstrate for the
first time that red raspberry extract has potent anticarci-
nogenic activity induced by DEN in a rat model. The
nodule incidence was decreased in a dose-dependent
manner. This study also first reported the incidence of
hepatic lesion in a DEN-induced rat model.
At the termination of the experiment, the rats were
necropsied, and grossly visible, tan nodu1es, which
bulged from the external and cut surface of the liver,
were found in the positive and red raspberry treated
groups. These nodules were analyzed by histopathologi-
cal staining. The main histopathological differential
diagnoses in the hepatic lesion tissues include hyperpla-
sia, fibrosis and hepatocellular carcinomas based on the
IARC classification of rodent tumors [23]. The normal
liver shows normal hepatocellular architecture mainly
consisting of normal hepatic parenchyma (Figure 3A
and 3B). The hepatic hyperplasia shows cell proliferation
and little difference from those in normal liver and the
cellular architecture of hepatocyte presented almost nor-
mal hepatocellular architecture (Figures 3C and 3D).
The hepatic fibrosis shows that nodules were also vari-
ably encased in fibroconnective tissue, which in turn
was invested by a rim of compressed hepatocytes (Fig-
ures 3E and 3F). The hepatocellular carcinoma shows
that within the nodular areas, bile ducts were scanty or
absent and lobular architecture was not preserved. The
individual intranodular hepatocytes were large, oval- or
irregular-shaped, and their cytoplasm was abundant.
The cytoplasm was loose and irregularly extensive
vacuolated with masses of acidophilic materials,
Figure 4 Transmission electronic microscope findings. The ultrastructures of normal hepatocyte shown in A, and DEN-induced neoplasm
cells in groups treated with low (B), middle (C) and high (D) doses raspberry treated groups. The neoplastic cells have an abundant cytoplasm
either finely and homogeneously granular, or containing multiple small cytoplasmic vacuoles or some widely scattered hyperchromatic variable-
sized nuclei, or rich endoplasmic reticulum, or appearing polyribosomes and monoparticulate glycogen.
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The nucleus was often binucleated and pleomorphic
nuclei with granular chromatin. Sometimes large baso-
philic hyperchromatic nuclei were also found (Figure
3H). The type of hepatocellular carcinomas is a kind of
highly malignant tumor and also the main cause of
death in hepatic cancer animals and hepatic cancer
patients, and is a main target for chemotherapy. Hepato-
cellular carcinomas are always accompanied by occur-
rence of distant metastasis and areas of necrosis,
ulceration, and hemorrhage [31,32]. Some phytochem-
icals, including curcumin, resveratrol, green tea cate-
chins, oltipraz and silibinin shown to suppress hepatic
carcinogenesis in experimental studies, possess promis-
ing chemopreventive and chemotherapeutic properties
[33,34]. These phytochemicals will bring wide perspec-
tives for liver cancer patients, specifically those with
hepatocellular carcinoma. Any potential agents are gen-
erally tolerated, nontoxic, inexpensive and sufficiently
bioavailable, and acceptable to patients by oral adminis-
tration. In our study, there was no toxicity observed in
the animals fed the red raspberry extract at the doses
tested. The pathological findings in this study showed
that there was 55.6% hepatocellular adenocarcinoma in
the control group and 25.0, 40.0, and 0% in the three
levels of low, middle, and high doses of red raspberry
treatment, respectively, during the 20-week study (P <
0.05). The ultrastructural findings showed that the neo-
plastic cells had an abundant cytoplasm either finely and
homogeneously granular, or containing multiple small
cytoplasmic vacuoles or some widely scattered hyper-
chromatic variable-sized nuclei, or rich endoplasmic
reticulum, or appearing polyribosomes and monoparti-
culate glycogen. Thus, red raspberry diet could not only
reduce nodule incidence, but also reduce markers of the
diagnostic features of the neoplasm. Red raspberry
might be a potential candidate agent of chemopreven-
tion or therapeutics for hepatocellular adenocarcinoma.
The major groups of phenolic compounds present in
red raspberries are reported to be anthocyanins, flavo-
nols, flavanols, ellagitannins, gallotannins, proanthocya-
nidins, and phenolic acids [35]. The major anthocyanins
and tannins identified are as follows: cyanidin-3-sophoro-
side, cyanidin-3-glucoside, pelargonidin-3-glucoside and
predominantly hydrolyzable tannins (ellagitannins and
gallotannins) as well as ellagic and gallic acid. A mixture
of 15 anthocyanidin 3-O-glycosides, cyaniding 3-gluco-
side, ellagic acid, and gallic acid decreased the prolifera-
tion of HT-29 cells in a dose - dependent manner [26].
These compounds are metabolized by the liver, imply-
ing the liver is directly exposed to these compounds by
compounds themselves or metabolites, which may
explain why the raspberry diet so effectively protected
the liver lesions against a DEN insult. However, we did
not analyze the phytochemical composition of this
extraction. The constituents of the red raspberry extract
used in this study as well as their bioavailability need to
be further analyzed.
Conclusion
In summary, our data suggested that fresh red raspberry
extract possesses potent activity to suppress DEN-
induced hepatic lesions in a rat model. The extracts not
only inhibited incidence of nodules, but also suppressed
the ratio of hepatocellular adenoma and reduced the
definite diagnostic features of neoplasm in a DEN-
induced rat model. However, the exact mechanism(s) of
how red raspberries prevent hepatic lesions needs to be
further studied.
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